Compliance as a Competitive Advantage The Novo Nordisk + Hims & Hers partnership also underscores a critical insight: compliance isnt just a box to checkits a differentiator
Vuskovich is skilled in patient education, medical affairs, sleep medicine, stroke prevention, medications, and other health and wellness topics
Bias To minimize bias, we consecutively enrolled all eligible patients based on predefined criteria
Thank you to our sponsors AG1 (Athletic Greens): Thesis: LMNT: Maui Nui Venison: InsideTracker: Supplements from Momentous Huberman Lab Premium Timestamps (00:00:00) Headache (00:03:51) Sponsors: Thesis, LMNT, Maui Nui, Momentous (00:07:47) Headache Sources: Muscle Tension
FDA grants accelerated approval to Novos Wegovy for treating MASH The US Food and Drug Administration (FDA) has granted accelerated approval to Novo Nordisks Wegovy (semaglutide) for the treatment of metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis, excluding those with cirrhosis